NCT02374125

Brief Summary

There is not a clear understanding of the origin of symptoms perceived by patients with impingement of the soft tissue structures of the subacromial space. Tendinopathy, tendon rupture or other pathologies, are present in asymptomatic subjects and subjects with symptoms and structural integrity can also be found. Patients diagnosed with subacromial impingement syndrome frequently have myofascial trigger points in the teres major muscle. Travell and Simons reported that the symptoms caused by trigger points in this muscle are similar to those experienced by patients diagnosed with impingement syndrome, but a literature search provides few results regarding relationship between subacromial impingement syndrome and presence of myofascial trigger points in the teres major muscle. This study aims to provide evidence of the results that can be obtained with a specific approach of teres mayor muscle by two manual techniques, Trigger Point Pressure Release and Diacutaneous Fibrolysis, in subjects with subacromial impingement syndrome, a condition that still representing both a diagnostic and therapeutic challenge. Secondary objective is to compare the outcomes between both techniques to select for each patient the most appropriate to their needs and characteristics.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
96

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2014

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2014

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 10, 2015

Completed
17 days until next milestone

First Posted

Study publicly available on registry

February 27, 2015

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2015

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

February 27, 2015

Status Verified

February 1, 2015

Enrollment Period

11 months

First QC Date

February 10, 2015

Last Update Submit

February 23, 2015

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Pain intensity (Using a VAS)

    Using a VAS

    Change from baseline to 3 weeks.

  • Change in Functional capacity (Abbreviated Constant-Murley score)

    Abbreviated Constant-Murley score

    Change from baseline to 3 weeks.

Secondary Outcomes (2)

  • Change in Active Range of Motion

    Change from baseline to 3 weeks.

  • Patient perception of change (Global Rating of Change scale)

    3 weeks after recruitment

Study Arms (3)

Fibrolysis Group

EXPERIMENTAL

Actual Diacutaneous Fibrolysis and protocolized physiotherapy

Device: Diacutaneous FibrolysisOther: Protocolized physiotherapy

Pressure Group

EXPERIMENTAL

Trigger Point Pressure Release and protocolized physiotherapy

Other: Trigger Point Pressure ReleaseOther: Protocolized physiotherapy

Control Group

ACTIVE COMPARATOR

Protocolized physiotherapy

Other: Protocolized physiotherapy

Interventions

Applied only around teres major muscle.

Fibrolysis Group

Applied only in teres major muscle trigger points.

Pressure Group

Exercises, TENS and cryotherapy

Control GroupFibrolysis GroupPressure Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years and over
  • Clinical diagnosis of Subacromial Impingement Syndrome.
  • Detectable trigger points in teres major muscle.
  • Sign informed consent form.

You may not qualify if:

  • Diacutaneous Fibrolysis contraindications
  • Previous shoulder surgery (\<1year)
  • Language barriers or cognitive issues that limit their ability to provide informed consent and participate in research.
  • Patients with a pending litigation or court claim.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Catalan Health Institut. Sant Ildefons Rehabilitation Service

Cornellà de Llobregat, Barcelona, 08840, Spain

RECRUITING

MeSH Terms

Conditions

Shoulder Impingement Syndrome

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesShoulder InjuriesWounds and Injuries

Study Officials

  • Martín Barra

    Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Martin Barra

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 10, 2015

First Posted

February 27, 2015

Study Start

November 1, 2014

Primary Completion

October 1, 2015

Study Completion

December 1, 2015

Last Updated

February 27, 2015

Record last verified: 2015-02

Locations